PrimaryLogo_Mango-05.png
MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product
05. Februar 2024 08:50 ET | Mangoceuticals, Inc.
The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ (a $498 value) for First 1,000 Subscribers Dallas, Texas,...
sphericalinsightsoptionblue.png
Global Continuous Renal Replacement Therapy Market Size To Hit USD 2.7 Billion By 2030 | CAGR of 8.91%
14. März 2023 07:30 ET | SPHERICAL INSIGHTS LLP
New York, United States , March 14, 2023 (GLOBE NEWSWIRE) -- The Global Continuous Renal Replacement Therapy Market Size to grow from USD 1.3 billion in 2021 to USD 2.7 billion by 2030, at a...
Future Market Insights.png
Hormone Replacement Therapy Market Is Set to Expand at a CAGR Of 5.7% To reach US$ 27.8 Billion By The Year 2032: FMI Companies Profiled in Hormone Replacement Therapy Market are Eli Lilly and Company, Pfizer, Inc., AbbVie, Inc., Novo Nordisk A/S, Merck KGaA, Mylan N.V., Bayer Healthcare, F. Hoffmann-La Roche Ltd.,...
visiongain Logo.png
Testosterone Replacement Therapy Market Report 2021-2031: Visiongain Research Inc.
03. August 2021 11:29 ET | Visiongain Ltd
Visiongain has published a new report on Testosterone Replacement Therapy Market Report 2021-2031: Forecasts By Product (Oral, Parenteral, Implants, Gel/Creams, Patches, Buccal Adhesive, and Others),...
SOB Top Logo.png
Steroids for sale - the dangers TRT patients are facing to avoid high cost prescriptions
25. März 2021 13:00 ET | Secrets Of Bodybuilding
LOS ANGELES, March 25, 2021 (GLOBE NEWSWIRE) -- Secrets Of Bodybuilding - TRT (Testosterone Replacement Therapy) has massively grown in popularity over the last six years giving many patients back...
AzurRx_Logo_CMYK.jpg
AzurRx BioPharma Announces Formation of Scientific Advisory Board
21. Oktober 2020 08:00 ET | AzurRx BioPharma, Inc.
Globally recognized experts in cystic fibrosis and chronic pancreatitis care and research to support AzurRx in advancing the clinical development of MS1819 NEW YORK, Oct. 21, 2020 (GLOBE NEWSWIRE)...